About Causaly
Causaly is a company based in London (United Kingdom) founded in 2017.. Causaly has raised $90.72 million across 5 funding rounds from investors including EBRD, Iconiq Capital and Index Ventures. The company has 62 employees as of December 31, 2023. Causaly offers products and services including AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG. Causaly operates in a competitive market with competitors including ScienceIO, Collaborative Drug Discovery, BioSymetrics, Citelighter and Qrativ, among others.
- Headquarter London, United Kingdom
- Employees 62 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Causaly Ltd
- Date of Incorporation 17 May, 2018
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$90.72 M (USD)
in 5 rounds
-
Latest Funding Round
$60 M (USD), Series B
Jul 13, 2023
-
Investors
EBRD
& 14 more
-
Employee Count
62
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Causaly
Causaly offers a comprehensive portfolio of products and services, including AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Unified system for life sciences R&D using AI and knowledge graphs.
Tool for querying and analyzing biomedical data with citations.
High-precision graph for causal relationships in life sciences.
Platform to consolidate internal and external data for R&D.
System for accurate retrieval of life sciences information.
Unlock access to complete
Funding Insights of Causaly
Causaly has successfully raised a total of $90.72M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $60 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $60.0M
-
First Round
First Round
(26 Jul 2018)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Series B - Causaly | Valuation | Iconiq Capital | |
| Oct, 2022 | Amount | Series A - Causaly | Valuation |
investors |
|
| May, 2021 | Amount | Series A - Causaly | Valuation | Index Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Causaly
Causaly has secured backing from 15 investors, including venture fund and angel investors. Prominent investors backing the company include EBRD, Iconiq Capital and Index Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of investment management and real asset services
|
Founded Year | Domain | Location | |
|
Venture capital investments in technology startups and entrepreneurs.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided to early-stage startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Causaly
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Causaly
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Causaly Comparisons
Competitors of Causaly
Causaly operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ScienceIO, Collaborative Drug Discovery, BioSymetrics, Citelighter and Qrativ, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI solutions transforming medical text into enriched healthcare data
|
|
| domain | founded_year | HQ Location |
Biological and chemical data are managed securely in a database.
|
|
| domain | founded_year | HQ Location |
Provider of a cognitive computing-based biomedical intelligence platform
|
|
| domain | founded_year | HQ Location |
Digital writing solution for K-20 students
|
|
| domain | founded_year | HQ Location |
AI based drug purposing platform to identify treatments for rare diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Causaly
Frequently Asked Questions about Causaly
When was Causaly founded?
Causaly was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Causaly located?
Causaly is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Causaly a funded company?
Causaly is a funded company, having raised a total of $90.72M across 5 funding rounds to date. The company's 1st funding round was a Series A of $17M, raised on Jul 26, 2018.
How many employees does Causaly have?
As of Dec 31, 2023, the latest employee count at Causaly is 62.
What does Causaly do?
Causaly was founded in 2017 and is headquartered in London, United Kingdom. The company operates in the biomedical AI sector, where software is developed to extract evidence from academic publications, clinical trials, regulatory documents, patents, and other sources. Hidden causal relationships in biomedical data are identified and curated through this technology, supporting researchers in cause-and-effect analysis.
Who are the top competitors of Causaly?
Causaly's top competitors include ScienceIO, BioSymetrics and Collaborative Drug Discovery.
What products or services does Causaly offer?
Causaly offers AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG.
Who are Causaly's investors?
Causaly has 15 investors. Key investors include EBRD, Iconiq Capital, Index Ventures, Marathon Venture Capital, and Pentech.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.